Q4 2025 Bio-Techne Corp Earnings Call Transcript

Aug 06, 2025 / 01:00PM GMT
Release Date Price: MXN2418.75
Operator

Good morning, and welcome to Bio-Techne earnings conference call for the fourth quarter and fiscal year 2025. (Operator Instructions)

I would now like to turn the call over to David Clair, Bio-Techne's Vice President, Investor Relations.

David Clair
Bio-Techne Corp - Vice President, Investor Relations & Corporate Development

Good morning, and thank you for joining us. On the call with me this morning are Kim Kelderman, President and Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne.

Before we begin, let me briefly cover our Safe Harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company's future results. The company's 10-K for fiscal year 2024 identifies certain factors that could cause the company's actual results to differ materially from those projected in the forward-looking statements made during this call. The company does not undertake to update any forward-looking statements because of any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot